All In Biotech

Free tool

FAERS Monitor: Norepinephrine Bitartrate In 0.9% Sodium Chloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214313 or its brand name (Norepinephrine Bitartrate In 0.9% Sodium Chloride, Norepinephrine Bitartrate). Reports on generic versions are filed under their own applications.

Reports

2,893

Serious

2,752

95% of reports

Hospitalization

1,305

Death reported

1,086

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective452
  • condition aggravated357
  • off label use316
  • hypotension291
  • multiple organ dysfunction syndrome286
  • sepsis268
  • cardiogenic shock233
  • stress229
  • general physical health deterioration215
  • hyponatraemia201
  • renal failure197
  • vomiting193
  • anaemia188
  • death188
  • nausea188

Reports by year received

View as table
YearReports
200424
200513
200648
200764
200835
200961
201042
2011217
201286
20132
20145
20154
201634
201736
201861
201993
2020125
2021183
2022174
2023241
2024226
2025670
2026448

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,266 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cardiogenic shockSignal233120.0106.026,945
multiple organ dysfunction syndromeSignal28674.166.420,384
hyponatraemiaSignal20126.022.84,810
stressSignal22923.220.54,836
sepsisSignal26817.515.64,167
general physical health deteriorationSignal21513.511.92,492
renal failureSignal19710.89.41,750
hypotensionSignal29110.69.52,530
condition aggravatedSignal3578.57.82,403
anaemiaSignal1887.26.21,001
vomitingSignal1933.02.6258
off label useSignal3162.62.4330
drug ineffectiveSignal4522.52.3430
nausea1881.71.559
death1881.61.442

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.